Innate immune receptors and autophagy: Implications for autoimmune kidney injury

Kidney International

Volumn 78, Issue 1, 2010, Pages 29-37

  Anders, Hans Joachim ^a   Schlondorff, Detlef O ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Autophagy; Danger signaling; Glomerulonephritis; Molecular mimicry; Toll like receptor

Indexed keywords

AUTOIMMUNE DISEASE; AUTOPHAGY; CD8+ T LYMPHOCYTE; IMMUNE RESPONSE; INNATE IMMUNITY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; REVIEW; ANIMAL; HUMAN; IMMUNOLOGY; INFECTION; INFLAMMATION; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

IMMUNOGLOBULIN RECEPTOR; TOLL LIKE RECEPTOR;

ANIMALS; AUTOPHAGY; HUMANS; INFECTION; INFLAMMATION; KIDNEY; KIDNEY DISEASES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 77953684865     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.111     Document Type: Review

References (101)

1. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826.
2. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289.
3. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007; 130: 25-35.
4. Kain R, Exner M, Brandes R et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008; 14: 1088-1096.
5. Hudson BG, Tryggvason K, Sundaramoorthy M et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-2556.
6. Morgan MD, Harper L, Williams J et al. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 2006; 17: 1224-1234.
7. Thorner PS, Ho M, Eremina V et al. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 2008; 19: 495-502.
8. Wolf D, Hochegger K, Wolf AM et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005; 16: 1360-1370. (Pubitemid 41716520)
9. Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol 2006; 17: 1253-1263.
10. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
11. Brown HJ, Lock HR, Wolfs TG et al. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol 2007; 18: 1732-1739.
12. Brown HJ, Lock HR, Sacks SH et al. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol 2006; 177: 1925-1931.
13. Brown HJ, Sacks SH, Robson MG. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 2006; 17: 1931-1939.
14. Fu Y, Xie C, Chen J et al. Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol 2006; 176: 632-639.
15. Leemans JC, Stokman G, Claessen N et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903.
16. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859.
17. Shigeoka AA, Holscher TD, King AJ et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 2007; 178: 6252-6258.
18. Lichtnekert J, Vielhauer V, Zecher D et al. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. Am J Physiol Renal Physiol 2009; 296: F867-F874.
19. Banas MC, Banas B, Hudkins KL et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713.
20. Yanai H, Ban T, Wang Z et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009; 462: 99-103.
21. Fairhurst AM, Xie C, Fu Y et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol 2009; 183: 6831-6838.
22. Sung SS, Bolton WK. T cells and dendritic cells in glomerular disease: the new glomerulotubular feedback loop. Kidney Int 2010; 77: 393-399.
23. Bolton WK, Chen L, Hellmark T et al. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. J Am Soc Nephrol 2005; 16: 2657-2666.
24. Wu J, Hicks J, Borillo J et al. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109: 517-524.
25. Chen L, Hellmark T, Pedchenko V et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2006; 17: 3076-3081.
26. Robertson J, Wu J, Arends J et al. Activation of glomerular basement membrane-specific B cells in the renal draining lymph node after T cell-mediated glomerular injury. J Am Soc Nephrol 2005; 16: 3256-3263.
27. Macconi D, Chiabrando C, Schiarea S et al. Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J Am Soc Nephrol 2009; 20: 123-130.
28. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286-1297.
29. Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol 2009; 20: 696-704.
30. Han GM, Chen SL, Shen N et al. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003; 4: 177-186.
31. Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007; 25: 419-441.
32. Means TK, Latz E, Hayashi F et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115: 407-417.
33. Savarese E, Chae OW, Trowitzsch S et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006; 107: 3229-3234.
34. Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005; 202: 1171-1177.
35. Peterson KS, Huang JF, Zhu J et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004; 113: 1722-1733.
36. Hägele H, Allam R, Pawar RD et al. Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoid acid-inducible gene (RIG)-I. Nephrol Dial Transplant 2009; 24: 3312-3318.
37. Fluer K, Allam R, Zecher D et al. Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via MDA5. Implications for viral infection-associated glomerulonephritis. Am J Pathol 2009; 175: 2014-2022.
38. Allam R, Lichtnekert J, Moll A et al. Viral RNA and DNA sense common antiviral responses including type I interferons in mesangial cells. J Am Soc Nephrol 2009; 20: 1986-1996.
39. Anders HJ, Krug A, Pawar RD. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus. Eur J Immunol 2008; 38: 1795-1799.
40. Christensen SR, Shupe J, Nickerson K et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417-428.
41. Savarese E, Steinberg C, Pawar RD et al. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 2008; 58: 1107-1115.
42. Pawar RD, Ramanjaneyulu A, Kulkarni OP et al. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 2007; 18: 1721-1731.
43. Pisitkun P, Deane JA, Difilippantonio MJ et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669-1672.
44. Lech M, Kulkarni OP, Pfeiffer S et al. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J Exp Med 2008; 205: 1879-1888.
45. Santiago-Raber ML, Dunand-Sauthier I, Wu T et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 2009 (e-pub ahead of print).
46. Nacionales DC, Kelly-Scumpia KM, Lee PY et al. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 2007; 56: 3770-3783.
47. Braun D, Geraldes P, Demengeot J. Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 2003; 20: 15-25.
48. Santiago-Raber ML, Baccala R, Haraldsson KM et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003; 197: 777-788.
49. Agrawal H, Jacob N, Carreras E et al. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol 2009; 183: 6021-6029.
50. Blanco P, Palucka AK, Gill M et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
51. Ronnblom L, Alm GV, Eloranta ML. Type I interferon and lupus. Curr Opin Rheumatol 2009; 21: 471-477.
52. Grimley PM, Davis GL, Kang YH et al. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. Lab Invest 1985; 52: 638-649.
53. Watanabe S, Ito T, Shirai M et al. Electron microscopic studies of peripheral blood mononuclear cells in chronic type C hepatitis treated with interferon-alpha. Ultrastruct Pathol 1995; 19: 1-8.
54. Strauss J, Abitbol C, Zilleruelo G et al. Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 625-630.
55. Rich SA. Human lupus inclusions and interferon. Science 1981; 213: 772-775.
56. Sharman A, Furness P, Feehally J. Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 2004; 19: 1420-1426.
57. Yang AH, Lin BS, Kuo KL et al. The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy. Nephrol Dial Transplant 2009; 24: 3419-3425.
58. Anders HJ. Pseudoviral immunity\a novel concept for lupus. Trends Mol Med 2009; 15: 553-561.
59. Torchinsky MB, Garaude J, Martin AP et al. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009; 458: 78-82.
60. Groeneveld AB, van Lambalgen TA, Thijs LG. Microvascular permeability in endotoxin and bacterial shock. Acute Care 1986; 12: 195-218.
61. Khandoga AG, Khandoga A, Anders HJ et al. Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes. Shock 2009; 31: 592-598.
62. Shimosawa M, Sakamoto K, Tomari Y et al. Lipopolysaccharide-triggered acute aggravation of mesangioproliferative glomerulonephritis through activation of coagulation in a high IgA strain of ddY mice. Nephron Exp Nephrol 2009; 112: e81-e91.
63. Pawar RD, Castrezana-Lopez L, Allam R et al. Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier. Immunology 2009; 128: e206-e221.
64. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.
65. Bagshaw SM, Langenberg C, Bellomo R. Urinary biochemistry and microscopy in septic acute renal failure: a systematic review. Am J Kidney Dis 2006; 48: 695-705.
66. Ka SM, Cheng CW, Shui HA et al. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Res Ther 2007; 9: R67.
67. Wolf G, Bohlender J, Bondeva T et al. Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 2006; 17: 1585-1593.
68. Wornle M, Schmid H, Banas B et al. Novel role of Toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-385.
69. Patole PS, Pawar RD, Lech M et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 2006; 21: 3062-3073.
70. Wilson HM, Walbaum D, Rees AJ. Macrophages and the kidney. Curr Opin Nephrol Hypertens 2004; 13: 285-290.
71. Pawar RD, Patole PS, Zecher D et al. Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 2006; 17: 141-149.
72. Patole PS, Grone HJ, Segerer S et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005; 16: 1326-1338.
73. Allam R, Pawar RD, Kulkarni OP et al. Viral 5-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses. Eur J Immunol 2008; 38: 3487-3498.
74. Anders HJ, Vielhauer V, Eis V et al. Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 2004; 18: 534-536.
75. Pawar RD, Patole PS, Ellwart A et al. Ligands to nucleic acid-specific Tolllike receptors and the onset of lupus nephritis. J Am Soc Nephrol 2006; 17: 3365-3373.
76. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004; 25: 381-386.
77. Mizushima N. Autophagy: process and function. Genes Dev 2007; 21: 2861-2873.
78. Mizushima N, Levine B, Cuervo AM et al. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
79. Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol 2009; 10: 461-470.
80. Deretic V. Multiple regulatory and effector roles of autophagy in immunity. Curr Opin Immunol 2009; 21: 53-62.
81. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007; 7: 767-777.
82. Schmid D, Munz C. Innate and adaptive immunity through autophagy. Immunity 2007; 27: 11-21.
83. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007; 26: 79-92.
84. Heath-Engel HM, Chang NC, Shore GC. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 2008; 27: 6419-6433.
85. Li Y, Wang LX, Yang G et al. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008; 68: 6889-6895.
86. Sanjuan MA, Dillon CP, Tait SW et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007; 450: 1253-1257.
87. Dorn BR, Dunn Jr WA, Progulske-Fox A. Bacterial interactions with the autophagic pathway. Cell Microbiol 2002; 4: 1-10.
88. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8: 594-606.
89. English L, Chemali M, Duron J et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009; 10: 480-487.
90. Crotzer VL, Blum JS. Autophagy and its role in MHC-mediated antigen presentation. J Immunol 2009; 182: 3335-3341.
91. Cooney R, Baker J, Brain O et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97.
92. Orvedahl A, Levine B. Eating the enemy within: autophagy in infectious diseases. Cell Death Differ 2009; 16: 57-69.
93. Jounai N, Takeshita F, Kobiyama K et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007; 104: 14050-14055.
94. Stetson DB, Ko JS, Heidmann T et al. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008; 134: 587-598.
95. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-569.
96. Urbonaviciute V, Furnrohr BG, Meister S et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007-3018.
97. Delgado MA, Elmaoued RA, Davis AS et al. Toll-like receptors control autophagy. EMBO J 2008; 27: 1110-1121.
98. Monroe JG, Keir ME. Bridging Toll-like-and B cell-receptor signaling: meet me at the autophagosome. Immunity 2008; 28: 729-731.
99. Meyer-Bahlburg A, Rawlings DJ. B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 2008; 7: 313-316.
100. Chaturvedi A, Pierce SK. Autophagy in immune cell regulation and dysregulation. Curr Allergy Asthma Rep 2009; 9: 341-346.
101. Hartleben B, Godel M, Meyer-Schwesinger C et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120: 1084-1096.